NBN GENE MUTATION

Clinical trials for NBN GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new NBN GENE MUTATION trials appear

Sign up with your email to follow new studies for NBN GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancer

Disease control Ongoing

This study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific genetic change in their tumor that may make it sensitive to this drug. The goal is to see if olaparib can shrink tumors or slow can…

Matched conditions: NBN GENE MUTATION

Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control

Last updated May 26, 2026 07:22 UTC

NBN GENE MUTATION

Get alerted when new NBN GENE MUTATION trials appear

New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancer